MANASSAS PARK, VA — In a tense courtroom on the morning of August 26, a judge ruled that Naresh Bhatt, 37, be held without bond following his arrest last week. The judge cited concerns that Bhatt ...

Naresh Malde, the founder of Pwani Oil Products Limited — one of East Africa’s most successful manufacturers of edible oils, soaps, and detergents — has passed away. Malde died on Saturday, October 25 ...

MANASSAS PARK, Va. — A judge has ruled Naresh Bhatt be held without bond during a hearing in court Monday morning. A judge said Bhatt was considered a flight risk following his arrest for allegedly ...

In an exclusive conversation with India Today, Dr. Naresh Trehan, Chairman MD, Medanta-The Medicity, discusses the surge in sudden deaths due to heart attacks in Karnataka's Hassan district and ...

Soon to be the official tool for managing Python installations on Windows, the new Python Installation Manager picks up where the ‘py’ launcher left off. Python is a first-class citizen on Microsoft ...

A startling milestone has been reached in Florida's war against the invasive Burmese pythons eating their way across the Everglades. The Conservancy of Southwest Florida reports it has captured and ...

Real-time clinical validation of a blood cell-free, mRNA-based GeneVerify test for screening and early diagnosis of prostate cancer. Circulating tumor DNA and late recurrence in high-risk, hormone ...

In an interview, Aditya Shreenivas, MD, MS, discussed the approval of penpulimab in nasopharyngeal carcinoma and the study that supports it. In April 2025, the FDA granted approval to the combination ...

“I was never studious,” Gulati tells The PIE News, recalling his struggles with school exams. “I could never relate myself to the education system.” Despite these early challenges, today, Gulati is a ...

This article was republished with permission from WTOP’s news partner InsideNoVa.com. Sign up for InsideNoVa.com’s free email subscription today. As the trial of Naresh Bhatt inches closer – on three ...

Naresh Chouhan, Intron Health principal, joins 'Squawk Box' to discuss why he's downgrading Novo Nordisk from buy to sell and slashing the target price. Got a confidential news tip? We want to hear ...